Incidence of ketoacidosis in the danish type 2 diabetes population before and after introduction of sodium-glucose cotransporter 2 inhibitorsda nationwide, retrospective cohort study, 1995-2014

Diabetes Care

Volumn 40, Issue 5, 2017, Pages e57-e58

  Jensen, Majken Linnemann ^a   Persson, Frederik ^a   Andersen, Gregers S ^a   Ridderstråle, Martin ^a   Nolan, John J ^a   Carstensen, Bendix ^a   Jørgensen, Marit E ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

COHORT ANALYSIS; DANISH CITIZEN; DENMARK; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFECT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRESCRIPTION; RETROSPECTIVE STUDY;

EID: 85018541396     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2793     Document Type: Letter

References (3)

1. Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K. The National Diabetes Register. Scand J Public Health 2011;39(Suppl.):58-61
2. Green A, Sortsø C, Jensen PB, Emneus M. Validation of the Danish National Diabetes Register. Clin Epidemiol 2014;7:5-15
3. Erondu N, Desai M, Ways K, Meininger G. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care 2015;38:1680-1686